City
Epaper

Onset of Covid pandemic soared antidepressant use in young girls: Study

By IANS | Updated: February 26, 2024 11:35 IST

New York, Feb 26 Antidepressant use rose sharply in adolescents and young adults, particularly among girls, after the ...

Open in App

New York, Feb 26 Antidepressant use rose sharply in adolescents and young adults, particularly among girls, after the Covid-19 pandemic began, according to a new study.

The findings, published in the journal Pediatrics, showed the rate of antidepressant use rose nearly 64 per cent faster after March 2020 in young people aged 12 to 25.

“Antidepressant dispensing to adolescents and young adults was already high and rising before March 2020. Our findings suggest these trends accelerated during the pandemic,” said lead author Kao Ping Chua, a paediatrician and researcher at University of Michigan Health C.S. Mott Children's Hospital in the US.

Importantly, the increase in the antidepressant dispensing rate during the pandemic was driven by females: 130 per cent faster among girls aged 12-17 years and 60 per cent faster among females aged 18-25 years.

“Multiple studies suggest that rates of anxiety and depression among female adolescents increased during the pandemic,” Chua said. “These studies, coupled with our findings, suggest the pandemic exacerbated a pre-existing mental health crisis in this group.”

In contrast to females, the antidepressant dispensing rate changed little among male young adults after March 2020 and declined among male adolescents, which Chua found surprising.

“It’s hard to believe this decline reflects improved mental health,” he said.

This could be because male adolescents may have skipped physicals and other health care visits during the pandemic, decreasing opportunities to diagnose and treat anxiety and depression, the researchers said.

Chua said the overall rise in antidepressant dispensing to adolescents and young adults may not only be related to worsened mental health. Long waitlists for psychotherapy, for example, may have also played a role.

“In my primary care clinic, I often heard from patients and families that they were facing 6-9 month wait lists for therapy during the pandemic. In those situations, it didn’t make sense to withhold antidepressants and recommend a therapy-only approach,” he said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalOhio's new Solicitor General Mathura Sridharan faces backlash, Attorney General defends her appointment

TechnologyQ1 Earnings Review: Brokerages give mixed outlook, earnings downgrade ratio drops

BusinessQ1 Earnings Review: Brokerages give mixed outlook, earnings downgrade ratio drops

NationalUP road tragedy: President Murmu expresses grief over loss of lives

InternationalBangladesh: Scores drown in Cox's Bazar sea beach in first six months of 2025

Technology Realted Stories

Technology172 hydrocarbon discoveries in 10 years, 62 offshore, as Modi govt opens ‘No-Go’ Zones: Hardeep Puri

TechnologyNMDC records over 42 pc jump in iron ore production in July

TechnologyFinolex Industries Q1 profit crashes 80 pc YoY, revenue down over 8 pc

TechnologyTop 10 largest firms shed Rs 1.35 lakh crore in a week; IT firms lead losses

TechnologyChatGPT may face capacity crunches ahead of GPT-5 launch: Sam Altman